Adenovirus 36 infection and obesity risk: current understanding and future therapeutic strategies.

Ana Carolina Lobor Cancelier Fabiana Schuelter Trevisol Daisson Jose Trevisol Richard L Atkinson

Published in: Expert review of endocrinology & metabolism (2022)

The role of Ad36 in the development of obesity has already been established. Future research should focus on the development of vaccines against this agent, drug discovery for infected individuals, and effective therapeutic uses of E4orf1 gene protein for diabetes and other diseases in clinical practice.

Keyphrases

drug discovery
type diabetes
insulin resistance
metabolic syndrome
weight loss
current status
high fat diet induced
weight gain
cardiovascular disease
glycemic control
copy number
adipose tissue
protein protein
dna methylation
skeletal muscle
small molecule
transcription factor
gene therapy
genome wide analysis